Mako Surgical Corp. - Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2008 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Dewey Christopher C

2. Date of Event Requiring Statement (MM/DD/YYYY) 2/14/2008

3. Issuer Name and Ticker or Trading Symbol

MAKO Surgical Corp. [MAKO]

(Last) (First) (Middle)

BOX 23, 173 LAMINGTON ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director ___ X ___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

OLDWICK, NJ 08858

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1409900	I	By Z-KAT, Inc. ⁽¹⁾

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Convertible Preferred Stock	12/17/2004	⁽²⁾	Common Stock	291372 ⁽²⁾	⁽²⁾	D
Series A Convertible Preferred Stock	1/11/2008	⁽²⁾	Common Stock	3300 ⁽²⁾ ⁽³⁾	⁽²⁾	I	By Daughter
Series A Convertible Preferred Stock	1/11/2008	⁽²⁾	Common Stock	3300 ⁽²⁾ ⁽³⁾	⁽²⁾	I	By Daughter
Series A Convertible Preferred Stock	6/29/2005	⁽²⁾	Common Stock	22984 ⁽²⁾	⁽²⁾	D
Series B Convertible Preferred Stock	7/14/2005	⁽²⁾	Common Stock	190019 ⁽²⁾	⁽²⁾	D
Series C Convertible Preferred Stock	2/6/2007	⁽²⁾	Common Stock	214302 ⁽²⁾	⁽²⁾	D
Common Stock Warrants (right to buy)	12/17/2004	12/17/2014	Common Stock	111182	$3.00	D

Explanation of Responses:
( 1)	The reporting person is a member of the board of directors of Z-KAT, Inc. and serves as the acting Chief Executive Officer of Z-KAT, Inc., but he disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
( 2)	The convertible preferred stock has no expiration date. As a result of a one-for-3.03 reverse split of MAKO Surgical Corp. common stock, each share of convertible preferred stock is convertible into .330033 of a share of common stock. Accordingly, upon the closing of the issuer's initial public offering, the convertible preferred stock will convert into the number of shares of common stock set forth in Column 3.
( 3)	The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.

Remarks:
Exhibit List
Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Dewey Christopher C BOX 23 173 LAMINGTON ROAD OLDWICK, NJ 08858	X	X

Signatures
/s/Menashe R. Frank, attorney in fact		2/14/2008
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.